ANIX
Anixa Biosciences·NASDAQ
--
--(--)
--
--(--)
7.69 / 10
Outperform
Liquidity flow is robust (7.46/10), with positive trends in block, large, and extra-large trades despite negative signals in small and medium flows. Analyst sentiment is overwhelmingly bullish, with a Strong Buy rating from one analyst and a historical win rate of 63.6%. This combination of strong fund inflows and positive analyst views offsets some of the technical and fundamental weaknesses.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-04
InstitutionD. Boral Capital
Times predicted11
Historical Win Rate63.6%
What is the analyst consensus for ANIX?
- ANIX holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.69/10 (Outperform).
